These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10155198)

  • 1. Results of recent trials on the progression of coronary artery disease and recurrent ischemic events: implications for interventional cardiology.
    Pitt B
    J Interv Cardiol; 1994 Dec; 7(6):515-8. PubMed ID: 10155198
    [No Abstract]   [Full Text] [Related]  

  • 2. [CARE[ Cholesterol and Recurrent Events Trial]].
    Oida K
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():427-32. PubMed ID: 11347108
    [No Abstract]   [Full Text] [Related]  

  • 3. Statin trials and goals of cholesterol-lowering therapy after AMI.
    Pedersen TR
    Am Heart J; 1999 Aug; 138(2 Pt 2):S177-82. PubMed ID: 10426879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coronary mortality lowered by 24%. Convincing results of the LIPID Study on Secondary Prevention].
    Z Kardiol; 1998 Apr; 87(4 Suppl Uberzeugen):1-3. PubMed ID: 9618895
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania P; Stone PH; Bairey Merz CN; Cosin-Aguilar J; Koylan N; Luo D; Ouyang P; Piotrowicz R; Schenck-Gustafsson K; Sellier P; Stein JH; Thompson PL; Tzivoni D
    Circulation; 2007 Feb; 115(6):700-7. PubMed ID: 17283260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
    Maron DJ
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):18-9. PubMed ID: 16265253
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of pravastatin on coronary events after myocardial infarction.
    Hazzard WR; Ettinger WH
    N Engl J Med; 1997 Mar; 336(13):961; author reply 962. PubMed ID: 9072700
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy and clinical trials.
    Bhatnagar D
    Curr Opin Lipidol; 1997 Jun; 8(3):U44-6. PubMed ID: 9211075
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-lowering therapy for average lipid levels: the CARE trial.
    Sprecher DL
    Cleve Clin J Med; 1997 Mar; 64(3):129-31. PubMed ID: 9068221
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary prevention.
    Am J Manag Care; 1998 Apr; 4(4 Suppl):S201-8. PubMed ID: 10184934
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary prevention of coronary artery disease.
    Domanski MJ
    N Engl J Med; 2007 Oct; 357(15):1543-5. PubMed ID: 17928603
    [No Abstract]   [Full Text] [Related]  

  • 13. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
    März W
    MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol reduction and coronary prevention.
    Prabhakaran D
    Natl Med J India; 1997; 10(1):24-5. PubMed ID: 9069704
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.
    Lewis SJ; Sacks FM; Mitchell JS; East C; Glasser S; Kell S; Letterer R; Limacher M; Moye LA; Rouleau JL; Pfeffer MA; Braunwald E
    J Am Coll Cardiol; 1998 Jul; 32(1):140-6. PubMed ID: 9669262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pravastatin on myocardial protection during coronary angioplasty and the role of adenosine.
    Lee TM; Su SF; Chou TF; Tsai CH
    Am J Cardiol; 2001 Nov; 88(10):1108-13. PubMed ID: 11703953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering cholesterol with drugs and diet.
    Pedersen TR
    N Engl J Med; 1995 Nov; 333(20):1350-1. PubMed ID: 7566029
    [No Abstract]   [Full Text] [Related]  

  • 18. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.
    Pitt B; Waters D; Brown WV; van Boven AJ; Schwartz L; Title LM; Eisenberg D; Shurzinske L; McCormick LS
    N Engl J Med; 1999 Jul; 341(2):70-6. PubMed ID: 10395630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP
    Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins for stroke: the second story?
    Plutzky J; Ridker PM
    Circulation; 2001 Jan; 103(3):348-50. PubMed ID: 11157683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.